The Food and Drug Administration said Friday that it would “rapidly work toward” issuing an emergency-use authorization for Pfizer and BioNTech’s coronavirus vaccine.
The Food and Drug Administration said Friday that it would “rapidly work toward” issuing an emergency-use authorization for Pfizer and BioNTech’s coronavirus vaccine.